Department of Gynecology and Obstetrics, Faculty of Medicine, Baskent University, Konya, Turkey.
Department of Urology, Faculty of Medicine, Baskent University, Konya, Turkey.
Medicine (Baltimore). 2024 Oct 4;103(40):e39940. doi: 10.1097/MD.0000000000039940.
This study aims to demonstrate the effectiveness of high-intensity focused ultrasound, a noninvasive treatment, for managing urinary incontinence (UI) in women. This is a single-center, retrospective study involving 28 women. Patients, aged between 32 and 65, were included. Patients with insulin-dependent diabetes, neurological disease, active urinary tract infection, undiagnosed vaginal bleeding, who had incontinence surgery, and receiving estrogen therapy were excluded from the study. Incontinence severity was evaluated with the International Incontinence Consultation Questionnaire Short Form (ICIQ-SF). Patients were evaluated before treatment and 6 months after treatment using the ICIQ-SF and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Assessment short form. In the analysis of numerical variables independent or paired t test or linear mixed effects models were used. Least square means were used in post hoc comparisons. Mean age of the patients was 45.50 ± 7.59 years. There were 18 (64%) stress urinary incontinence (SUI) and 10 (36%) mixed urinary incontinence (MUI). Six months after treatment, mean ICIQ-SF and Pelvic Organ Prolapse/Urinary Incontinence Short Form Questionnaire scores showed a significant positive change. After the procedure, UI completely disappeared in 43% of the patients. The rate of severe UI decreased from 39% to 8%, and very severe UI decreased from 8% to 0%. Incontinence severity was significantly different in the MUI and SUI groups before and after the procedure. After the procedure, UI completely disappeared in 67% of the patients in the SUI group, while it remained at a mild level in 33%. The decrease in ICIQ-SF score in the SUI group was significantly higher than that in the MUI group. There were no severe adverse events, in 4 patients there was mild vaginal discharge which resolved in 1 week. This study showed that high-intensity focused ultrasound treatment, can be effective and safe even in a single session. Selection and recall biases are potential biases in retrospective studies. Lacking a control group is another limitation. Although advances in technology are very important for medical treatments, their effectiveness and safety need to be proven. Future research in this area with a larger sample size and a prospective design will offer further evidence supporting effectiveness of this treatment model.
本研究旨在展示高强度聚焦超声(HIFU)这一非侵入性治疗方法在女性尿失禁(UI)管理中的有效性。这是一项单中心回顾性研究,共纳入 28 名女性患者。纳入的患者年龄在 32 岁至 65 岁之间,排除了患有胰岛素依赖型糖尿病、神经系统疾病、活动性尿路感染、原因不明的阴道出血、曾接受过尿失禁手术和正在接受雌激素治疗的患者。尿失禁严重程度采用国际尿失禁咨询问卷简表(ICIQ-SF)进行评估。患者在治疗前和治疗后 6 个月分别采用 ICIQ-SF 和盆腔器官脱垂/尿失禁性功能评估简表进行评估。在分析数值变量时,使用独立或配对 t 检验或线性混合效应模型。事后比较采用最小二乘均数。患者的平均年龄为 45.50±7.59 岁。其中 18 例(64%)为压力性尿失禁(SUI),10 例(36%)为混合性尿失禁(MUI)。治疗 6 个月后,ICIQ-SF 和盆腔器官脱垂/尿失禁性功能评估简表评分均显示出显著的阳性变化。治疗后,43%的患者完全消除了尿失禁,39%的严重尿失禁患者降至 8%,8%的极严重尿失禁患者降至 0%。治疗前后 MUI 和 SUI 组的尿失禁严重程度差异有统计学意义。治疗后,SUI 组 67%的患者完全消除了尿失禁,33%的患者尿失禁仍处于轻度水平。SUI 组 ICIQ-SF 评分的下降明显高于 MUI 组。无严重不良事件,4 例患者出现轻度阴道排液,1 周内缓解。本研究表明,高强度聚焦超声治疗单次治疗即可有效且安全。回顾性研究存在选择偏倚和回忆偏倚。缺乏对照组是另一个局限性。尽管技术进步对医疗非常重要,但它们的有效性和安全性需要得到验证。未来在该领域进行的、样本量更大、前瞻性设计的研究将提供更多支持这种治疗模式有效性的证据。